Alfar, which is currently undergoing a significant restructuring and core process review, was keen to apply industry best-practice processes, and replace its own “home-made” solution which was no longer able to support the increasingly higher transaction demands and constant changes characteristic of today’s market conditions. To that end Alfar chose high performing and state-of-the-art solutions from IBS.
“We were looking for a reliable partner who understood the specific demands of pharmaceutical distribution, provided state-of-the-art technology, and could provide us with the confidence of a long-term partnership into the future. We evaluated some other possible solutions within Italian market and we chose IBS Pharma as “the” solution and IBS FasTrax “the” implementation methodology, said Dott.ssa Caterina Tartara, Member of Alfar’s Executive Board. FasTrax will enable us to speed up process development time, keep the costs under control, and take full advantage of all IBS Pharma functionalities. IBS’ proven experience within distribution, and more specifically within the pharmaceutical market, inspires us with the confidence that we will gain great results from our process review.”
“We are very proud that Alfar chose IBS as their strategic partner for growth, especially at such a critical moment, with reference to both their own internal process review as well as the current market conditions.
We are aware of the upmost importance of information systems such as ours within a firm such as Alfar. After all our systems run the business, and help ensure pharmaceutical distribution core requirement such as state-of-the-art customer service levels, “around the clock” system availability, and “open” customer communications, are delivered effectively. With pharmaceutical distribution being a key industry sector for IBS, Alfar’s choice is another solid endorsement of our expertise and solution delivery in the sector” said Andy Bailey, Chief Marketing Officer IBS AB.
For further information please contact:
Jeanette Cronstedt Lind
IBS Sverige AB
Tel: +46-8-627 25 73
ALFAR-ALESSANDRIA FARMACEUTICI EREDI DOTT.CARLO TARTARA SRL is a pharmaceutical distributor working in Italy since 60 years.
Founded in 1951 by Dott. Carlo Tartara, it offers high targeted distribution services in Alessandria and Asti provinces, within Piemonte region of Italy.
The Executive Board is currently composed by Dott. Carlo Tartara’s daughters,: Caterina, Elena and Francesca Tartara.
The company is headquartered in Alessandria (Piemonte).
IBS in brief
With over 30 years of experience, IBS is a leading provider of distribution management solutions. IBS focuses on industries such as automotive, electrical components, paper & packaging and pharmaceutical distribution. More than 4,000 customers across some 40 countries use IBS software to gain fast and measurable returns on IT investments.
IBS B share is listed on NASDAQ OMX First North Exchange Stockholm. For more information, please visit http://www.ibs.net